J&J Unit Slammed With $70M Verdict In Philly Risperdal Trial
A Johnson & Johnson unit was slapped with a $70 million verdict on Friday as a Philadelphia jury found that the antipsychotic drug Risperdal had caused an adolescent boy to grow...To view the full article, register now.
Already a subscriber? Click here to view full article